Latest week
10 Jul 2026
Close
76.120003
Fair value
82.000215
Next-week expectancy
Undecided 52.31%
Sharemaestro

SNW Chart Pack

Sanofi

Exchange
GER
Latest week
10 Jul 2026
Close
76.120003
Fair value
82.000215
Next-week expectancy
Undecided 52.31%
Generated
16 Jul 2026 20:20
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, SNW rose 0.35%, moving from 75.86 to 76.12. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.25 and has softened across the 12-week window. Market Dynamics is 0.46 on the latest week. Next-week expectancy is undecided at 52.31% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
76.12
12-Week Change
0.35%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.31%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-5.25
Market Dynamics
0.46

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
76.12
12-Week Change
0.35%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 52.31%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-5.25
Market Dynamics
0.46

Over the latest 12 completed weeks ending 2026-07-10, SNW rose 0.35%, moving from 75.86 to 76.12. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -5.25 and has softened across the 12-week window. Market Dynamics is 0.46 on the latest week. Next-week expectancy is undecided at 52.31% based on similar historical setup states.

Industry Peers

Germany equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
GIS Gilead Sciences, Inc. GER 10 Jul 2026 115.02 120.80 112.54 114.86 -0.14%
PFE Pfizer Inc. GER 10 Jul 2026 21.28 21.37 20.72 21.22 -0.31%
BRM Bristol-Myers Squibb Company GER 10 Jul 2026 50.60 51.06 49.58 50.20 -0.79%
JNJ Johnson & Johnson GER 10 Jul 2026 229.50 235.65 225.25 226.15 -1.46%
NOV Novo Nordisk A/S GER 10 Jul 2026 43.90 44.19 42.33 43.13 -1.77%
AMG Amgen Inc. GER 10 Jul 2026 325.40 327.65 316.00 318.55 -2.11%
RHO Roche Holding AG GER 10 Jul 2026 376.40 377.40 363.60 368.00 -2.23%
LLY Eli Lilly and Company GER 10 Jul 2026 1062.80 1090.80 1036.80 1037.80 -2.35%
GS71 GSK plc GER 10 Jul 2026 23.70 23.91 22.92 22.98 -3.04%
NOT NOVARTIS AG N GER 10 Jul 2026 139.40 139.68 134.48 134.60 -3.44%
BAYN Bayer Aktiengesellschaft GER 10 Jul 2026 53.06 53.78 49.36 50.12 -5.54%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.